CH669909A5 - - Google Patents

Download PDF

Info

Publication number
CH669909A5
CH669909A5 CH165/88A CH16588A CH669909A5 CH 669909 A5 CH669909 A5 CH 669909A5 CH 165/88 A CH165/88 A CH 165/88A CH 16588 A CH16588 A CH 16588A CH 669909 A5 CH669909 A5 CH 669909A5
Authority
CH
Switzerland
Prior art keywords
sms
pharmaceutical compositions
compositions according
polypeptide
ether
Prior art date
Application number
CH165/88A
Other languages
German (de)
English (en)
Inventor
Jacky Vonderscher
Joachim Franz
Michel Steiger
Karl Hornung
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of CH669909A5 publication Critical patent/CH669909A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/31—Somatostatins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
CH165/88A 1986-05-27 1988-05-22 CH669909A5 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH2138/86A CH667994A5 (de) 1986-05-27 1986-05-27 Pharmazeutische zusammensetzungen mit polypeptid-wirkstoffen.

Publications (1)

Publication Number Publication Date
CH669909A5 true CH669909A5 (fr) 1989-04-28

Family

ID=4226759

Family Applications (2)

Application Number Title Priority Date Filing Date
CH2138/86A CH667994A5 (de) 1986-05-27 1986-05-27 Pharmazeutische zusammensetzungen mit polypeptid-wirkstoffen.
CH165/88A CH669909A5 (fr) 1986-05-27 1988-05-22

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CH2138/86A CH667994A5 (de) 1986-05-27 1986-05-27 Pharmazeutische zusammensetzungen mit polypeptid-wirkstoffen.

Country Status (5)

Country Link
JP (1) JPS62283930A (fr)
CH (2) CH667994A5 (fr)
IT (1) IT1216814B (fr)
PT (1) PT84943B (fr)
ZA (1) ZA873841B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007535545A (ja) * 2004-04-28 2007-12-06 プロキャリア・インコーポレーテッド 難吸収性薬剤の経口投与のための製剤
JP2011519928A (ja) 2008-05-07 2011-07-14 メリオン・リサーチ・Ｉｉｉ・リミテッド ペプチドの組成物及びその調製方法
US20110182985A1 (en) * 2010-01-28 2011-07-28 Coughlan David C Solid Pharmaceutical Composition with Enhancers and Methods of Preparing thereof
US9089484B2 (en) 2010-03-26 2015-07-28 Merrion Research Iii Limited Pharmaceutical compositions of selective factor Xa inhibitors for oral administration
EP3250191B1 (fr) 2015-01-29 2024-01-17 Novo Nordisk A/S Comprimés contenant un agoniste de glp-1 et revêtement gastro-résistant

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57146722A (en) * 1981-03-06 1982-09-10 Toyo Jozo Co Ltd Pharmaceutical preparation having improved absorption

Also Published As

Publication number Publication date
IT1216814B (it) 1990-03-14
ZA873841B (en) 1989-01-25
PT84943A (en) 1987-06-01
JPS62283930A (ja) 1987-12-09
IT8747977A0 (it) 1987-05-25
CH667994A5 (de) 1988-11-30
PT84943B (pt) 1990-03-08

Similar Documents

Publication Publication Date Title
DE69203488T3 (de) Niedrigdosierte getrocknete pharmazeutische Präparate.
WO1987007149A1 (fr) Compositions pharmaceutiques
DE60017156T2 (de) Feste lipidformulierung enthaltend lipasehemmer und fettsäureester von polyolen
EP0128482A2 (fr) Formes galéniques d'antidiabétiques orales et procédé de leur préparation
DE19543271A1 (de) Orales pharmazeutisches Präparat
DD142149A5 (de) Verfahren zur herstellung resorbierbarer galenischer kompositionen
DE3887494T2 (de) Ein Calcitonin sowie ein Glycyrrhizinat als Absorptionsförderer enthaltende Arzneimittel.
DE60222908T2 (de) Neue dammaran-sapogenine, ihre verwendung als krebsmittel sowie ein verfahren zu ihrer herstellung
AT395819B (de) Wasserloesliche monoester als solubilisatoren fuer pharmakologische wirkstoffe und pharmazeutische hilfsstoffe
DE60308679T2 (de) Methode zur behandlung oder prävention immunologischer erkrankungen und pharmazeutische zusammensetzung zur solchen anwendung
EP0722719B1 (fr) Procédé de fabrication de préparations à base de flavano-lignanes
CH677320A5 (fr)
EP0399051B1 (fr) Agent anti-inflammatoire polyvalent
DE2759171A1 (de) Arzneimittel mit wirkung als prostaglandinsynthetaseninhibitor
CH669909A5 (fr)
DE2732335A1 (de) Neue pharmazeutische zusammensetzung und verfahren zu deren herstellung
DE3602577A1 (de) 9,10-dihydrogenierte ergotalkaloide enthaltende pharmazeutische zusammensetzungen
DE69125204T2 (de) Therapeutische Anwendung von Histamin-H3-Agonisten, neue Wirkstoffe und Verwendung zur Herstellung von Arzneimitteln
DE60210626T2 (de) Verbesserte pharmazeutische zusammensetzung mit einem ppar-alpha-mittel und verfahren zu ihrer herstellung
EP1886694B1 (fr) Formulation pérorale contenant le diénogest et l'éthinylestradiole comme contraceptif
DE3904795C2 (de) Pharmazeutisches Präparat und dessen Verwendung
DE69927599T2 (de) Verwendung von wachstumshormon und analoga davon für die behandlung von säugern mit familiärer hypercholesterolämie
DE3830494B4 (de) Wasserlösliche Monoester als Solubilisatoren für pharmakologische Wirkstoffe und pharmazeutische Hilfsstoffe
KR100245670B1 (ko) 종양괴사인자 매개성 피부질환 치료제 조성물
DE69103294T2 (de) Verwendung der 3-Oxygermylpropionsäure zur Behandlung und Prävention von Diabetes verursacht durch Autoimmunkrankheiten.

Legal Events

Date Code Title Description
PFA Name/firm changed

Owner name: SANDOZ AG TRANSFER- NOVARTIS AG

PL Patent ceased